Condition
Recurrent Adult Diffuse Small Cleaved Cell Lymphoma
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 10 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
10 shownGenetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin LymphomaNCT01769911 · 2015-02-01
WITHDRAWNIbrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV InfectionNCT02109224 · 2014-09-01
TERMINATEDMechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell TransplantNCT01558778 · 2012-05-01
WITHDRAWNDeferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic MalignanciesNCT01273766 · 2011-01-01
COMPLETEDDeferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron OverloadNCT01159067 · 2010-07-01
TERMINATEDRO4929097 and Capecitabine in Treating Patients With Refractory Solid TumorsNCT01158274 · 2010-06-01
COMPLETEDSunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral TherapyNCT00890747 · 2009-08-01
COMPLETEDOndansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell TransplantNCT00795769 · 2008-08-08
COMPLETEDLithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell TransplantNCT00408681 · 2006-06-01
COMPLETEDFlavopiridol in Treating Patients With Relapsed or Refractory Lymphoma or Multiple MyelomaNCT00112723 · 2005-12-01
TERMINATEDCommon interventions
laboratory biomarker analysisOTHER6deferasiroxDRUG2management of therapy complicationsPROCEDURE2Pharmacological StudyOTHER2alvocidibDRUG1autologous hematopoietic stem cell transplantationPROCEDURE1capecitabineDRUG1carmustineDRUG1cytarabineDRUG1enzyme-linked immunosorbent assayOTHER1etoposideDRUG1gamma-secretase/Notch signalling pathway inhibitor RO4929097DRUG1IbrutinibDRUG1lithium carbonateDRUG1melphalanDRUG1musculoskeletal complications management/preventionPROCEDURE1O6-benzylguanineDRUG1ondansetronDRUG1peripheral blood stem cell transplantationPROCEDURE1sunitinib malateDRUG1survey administrationOTHER1
Leading sponsors
Trial status mix
COMPLETED5
TERMINATED3
WITHDRAWN2
Phase mix
PHASE14
PHASE24
NA3
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.